To our Valued Patients, Customers and Health Care providers,
As we navigate through these trying times surrounding the Coronavirus (COVID-19) pandemic, we at OncoBeta are compelled to share our participation and support through this difficult situation with you. We are committed to maintain our services and business activities in order to support you as best possible. It is only through the great efforts of our team that we are able to achieve this goal. All of our “non-production” personnel are working from home. All production relevant personnel produce as the need arises while maintaining the highest level of safety measures. As a company owned by family offices, it is particularly important for us to care about the health and well-being of our team, our patients and our customers during these challenging times.
It is OncoBeta’s mission to improve the quality of life of patients suffering from non-melanoma skin cancer. We are pleased to inform you that in some countries the Rhenium-SCT will be used to treat certain Oncology patients that were scheduled for surgery prior to the initiation of COVID-19 protection measures. Patients treated with the Rhenium-SCT are out-patients and by offering this as an alternative treatment, beds and operating room space remain free for COVID-19 patients.
In the face of the COVID-19 global pandemic OncoBeta’s team is still working continuously on an international scale to respond to Patient’s, Customer’s and Health Care provider’s needs, upholding an “up to date” information flow and maintaining supply.
We are very appreciative of the continuous confidence and support placed in our team and our products.
We are here for you to answer any questions you might have regarding the impact that COVID-19 measures might have on your Rhenium-SCT therapy. Please contact your local Rhenium-SCT treatment center or us directly at email@example.com should you have any questions.
On behalf of the OncoBeta family, stay home, stay healthy and stay well.
Shannon D. Brown III
CEO and Managing Director